Navigation Links
FDA's Just Approved Monthly Drug Treatment, Vivitrol Could Be 'Game Changer,' Says Country's Largest Drug Treatment Recovery President, CRC's Jerry Rhodes; Provides Addicts 'One Decision A Month Instead of 30'
Date:10/12/2010

WASHINGTON and CUPERTINO, Calif., Oct. 12 /PRNewswire-USNewswire/ -- "The FDA's just approved monthly drug treatment with Vivitrol could be a game changer," said the country's largest substance abuse treatment provider, CRC Health Group, Recovery Division President Jerry Rhodes, whose company has 140 facilities across the country. Rhodes said the new treatment regimen "will provide addicts seeking help one decision a month instead of 30, and a new way to reduce or eliminate relapse. We are pleased to play a part in rolling out this potentially life-saving treatment."

Former U.S. Drug Czar, General Barry McCaffrey, now on CRC's Board, congratulated the FDA and CRC "for adopting a science-based new approach to reduce the national drug treatment gap. Addicts who in the past have been reluctant to seek treatment will be far more likely with a once-a-month opportunity to stop their craving. This is another important new tool in treatment."

Rhodes and McCaffrey offered "thanks and congratulations" to Alkermes Inc for developing and providing the medication approved today by the FDA and to be used by CRC facilities.

Rhodes stated that CRC has been utilizing Vivitrol to treat alcoholism "for years with extremely positive results" and is now in the process of developing the protocols and formulations for therapy for opiate patients. He stated that "every patient is an individual case. Vivitrol will be among the treatment options doctors will now have available, in addition to already existing Methadone and Suboxone (buprenorphine). In all cases, counseling and monitoring are a crucial part of treatment."

McCaffrey added, "The abuse of opioids like prescription pain medications and heroin is on the rise. Prescription drug abuse has tripled in the past decade – it's the new heroin. Nearly 16 million Americans ages 12 and older misused or abused prescription drugs or heroin in 2008 according to SAMHSA's National Survey on Drug Use and Health
'/>"/>

SOURCE Robert Weiner Associates and CRC Health Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
3. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
4. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
5. Newly Approved HIV Drug Shows Great Promise
6. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
7. Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
8. Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
9. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Fla. , July 29, 2014 /PRNewswire-iReach/ -- ... service provider, has launched its Medical Equipment ...  These services are tailored to the cruise ... standards prompted industry operators to propose that they ... MHG Medical,s new program is intended to create ...
(Date:7/29/2014)... York , July 29, 2014 ... Transparency Market Research "Orthopedic Trauma Fixation Devices Market - ... 2014 - 2020", the global orthopedic trauma fixation devices ... and is expected to grow at a CAGR of ... value of USD 9.3 billion in 2020. ...
(Date:7/29/2014)... and TORONTO , ... Corporation (OTCBB: ESAQ), an emerging pharmaceutical company ... of improved novel formulations and alternative dosage ... expansion of its pharmaceutical development implementing its sub-micron ... large molecule drugs that will address indications ...
Breaking Medicine Technology:MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4
(Date:7/29/2014)... As the Ebola outbreak in Liberia worsens, ... both purchase critical emergency supplies locally, as well as ship ... supplies will contain materials used to control the spread of ... of the country. , With a large programmatic presence ... the Ebola outbreak in the region. The current epidemic remains ...
(Date:7/29/2014)... 29, 2014 Many people complain about their ... do each morning is put on glasses to see their ... same individuals also may be dissatisfied with their vision even ... Cataracts may cause difficulty driving, especially at night due to ... find one’s golf ball, see the TV, sew or cross ...
(Date:7/29/2014)... Thompson HealthDay Reporter , TUESDAY, ... and good sleep can protect the body against the negative ... a cellular level, researchers report. A study involving hundreds ... increased shortening of telomeres, the protective caps at the ends ... found that over a one-year period, the more stressors a ...
(Date:7/29/2014)... of living donor kidney transplants receive steady follow-up ... be monitored. To make follow-up care more accessible, ... WAG) are collaborating to launch the first program ... at no charge to living kidney donors. , ... redeemable at more than 4,500 Walgreens pharmacies and ...
(Date:7/29/2014)... Most people want to turn back the clock ... about their appearance. There are anti aging microcurrent ... that can help them to look their absolute best. ... oriented anti-aging procedures that are noninvasive and they adding some ... with cellulite. To accommodate, they are also in the ...
Breaking Medicine News(10 mins):Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 2Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 3Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 3Health News:Caring for donors 2Health News:Caring for donors 3Health News:Supreme Skin Announces Plans for a Grand Re-opening for Their Noninvasive Anti Aging Microcurrent Face and Body Treatments In Asheville, NC 2
... 9 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... the development, manufacture and commercialization of,a broad range of ... announced financial results for the fourth quarter and fiscal ... Financial Results , Revenue in ...
... of baby boomers with eye-ailments and soaring medical ... diet supplements to protect their eyes and curb ... supplements to alleviate blinding diseases such as age-related ... growth avenues in the market.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... (Dublin, Ohio), the psychiatric practice of Adam Brandemihl, M.D., Board Certified ... Adult ADD. He discusses ten ways of coping with adult ADD ... ... 9, 2009 -- With the continued recession and struggling economy, keeping ...
... as the community,s new medical director. White, a Board-certified internal and ... substantial, relevant experience to Park Springs, a continuing care retirement community ... ... March 6, 2009 -- Park Springs is pleased to announce Dr. ...
... treatment provider and renowned male hormone replacement experts ... publicity concerning professional athletes within MLB testing positive ... growth hormone) may have on men suffering from ... negative image being portrayed by professional athletes -- ...
... analysis has found that certain variations in genes that ... Hodgkin disease. Published in the April 1, 2009 issue ... American Cancer Society, the study indicates that differences in ... individuals, susceptibility to this type of cancer. , Proteins ...
Cached Medicine News:Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 9Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 2Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 3Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 4Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 5Health News:How to Win the Battle with Adult ADD in the Workplace 2Health News:How to Win the Battle with Adult ADD in the Workplace 3Health News:Park Springs Names New Medical Director 2Health News:Park Springs Names New Medical Director 3Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 2Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 3Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 4Health News:DNA differences may influence risk of Hodgkin disease 2
... The National Laboratory Training Network (NLTN) ... Association of Public Health Laboratories (APHL) and ... (CDC). NLTN provides cost-effective training in a ... resources, including a FREE Lending Library. Log ...
... The AAFP-PT Laboratory Proficiency Testing and Quality ... are designed to assist POLs, clinics and ... designed to assure accuracy of patient lab ... requirements. Participation provides the opportunity to earn ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
Medicine Products: